Welcome to our dedicated page for Crescent Capital Bdc news (Ticker: CCAP), a resource for investors and traders seeking the latest updates and insights on Crescent Capital Bdc stock.
Crescent Capital BDC Inc (NASDAQ: CCAP) delivers essential financing solutions to U.S. middle-market companies through structured debt and strategic equity investments. This news hub provides investors and financial professionals with centralized access to the company's latest developments, regulatory filings, and market-moving announcements.
Track critical updates including quarterly results, portfolio company activity, capital structure changes, and leadership developments. Our curated news feed combines press releases with verified financial reporting, offering transparent insights into CCAP's disciplined investment approach and middle-market positioning.
Discover timely information on credit facility expansions, dividend declarations, and strategic portfolio adjustments. All content undergoes rigorous verification to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of CCAP's evolving role in middle-market finance. Combine our news updates with SEC filings and earnings transcripts for comprehensive analysis of the company's risk-managed growth strategy.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) announced it will release its financial results for Q2 2022 on August 10, 2022, after market close. A webcast and conference call to discuss these results will occur on August 11, 2022, at 12:00 PM ET. Crescent BDC aims to maximize total returns for stockholders by providing capital solutions to middle-market companies with strong growth prospects. It is externally managed by Crescent Cap Advisors, a subsidiary of Crescent Capital Group, which manages over $38 billion in assets.
Crescent Capital BDC (CCAP) reported net investment income of $12.1 million ($0.39 per share) for Q1 2022, with an adjusted net income of $12.9 million ($0.42 per share). The net asset value per share rose to $21.18 from $21.12 in Q4 2021. The company declared a regular cash dividend of $0.41 per share for Q2 2022, payable July 15. Total investments increased to $1,288.6 million, with investment income up to $26.4 million from $20.6 million year-over-year.
Crescent Capital BDC (NASDAQ: CCAP) will announce its financial results for Q1 2022 on May 9, 2022, post-market. A conference call is scheduled for May 10, 2022, at 12:00 p.m. ET to discuss these results. Participants can join via the company's website or by calling (855) 982-6679 (domestic) or (614) 999-9468 (international) with Conference ID: 9787085. Crescent BDC aims to maximize stockholder returns through capital solutions for middle-market firms.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) reported strong financial results for the year ended December 31, 2021, with net investment income of $47.6 million ($1.67 per share) and adjusted net investment income of $53.9 million ($1.89 per share). The company declared a regular cash dividend of $0.41 per share for Q1 2022, along with a special cash dividend of $0.05 per share. Total investments at fair value reached $1.27 billion, with a net asset value per share of $21.12. Notably, Crescent Capital increased its investment income by 22% year-over-year, driven by substantial net deployment.
Crescent Capital BDC will release its financial results for Q4 and fiscal year ended December 31, 2021, on February 23, 2022, after market close. A conference call will be held the following day, February 24, 2022, at 12:00 p.m. ET, where management will discuss the results. Interested parties can join via the company's website or by phone. Crescent BDC, a business development company, aims to provide capital solutions to middle-market companies, maximizing returns through current income and capital appreciation.
Crescent Capital BDC, Inc. (CCAP) has priced an underwritten offering of 2,500,000 shares of its common stock at $21.33 per share, aiming to raise approximately $53.3 million in net proceeds. An option to purchase an additional 375,000 shares is granted to underwriters. The offering follows the Company's shelf-registration statement approved by the SEC and is expected to close on November 18, 2021. Proceeds will be used for general corporate purposes, including debt repayment and investments in portfolio companies.
Crescent Capital BDC, Inc. (NASDAQ: CCAP) announced a primary offering of 2,500,000 shares of common stock, with an option for underwriters to purchase an additional 375,000 shares. The offering is registered with the SEC, and the proceeds will be utilized for general corporate purposes, including debt repayment and investments. Crescent's investment adviser will pay underwriters a supplemental payment to cover the difference between the actual offering price and net proceeds. The offering will be managed by multiple financial institutions, including BofA Securities and Wells Fargo.
Crescent Capital BDC (CCAP) reported a net investment income of $12.7 million ($0.45 per share) for Q3 2021, up from $11 million in Q2 2021. Adjusted net investment income was $13.5 million ($0.48 per share). The net asset value per share rose to $21.16 compared to $20.98 in the previous quarter. The firm declared cash dividends totaling $0.41 per share for regular dividends and additional special dividends worth $0.05 each. Investments at fair value increased to $1,138.6 million, with a portfolio comprising 132 companies.
Crescent Capital BDC (NASDAQ: CCAP) will release its third-quarter financial results for the period ending September 30, 2021, on November 10, 2021, after market close. A conference call to discuss these results is scheduled for November 11, 2021, at 12:00 p.m. Eastern Time, accessible via their investor relations website. Crescent BDC focuses on maximizing stockholder returns by providing capital solutions to middle-market companies. The firm is managed by Crescent Cap Advisors, a subsidiary of Crescent Capital Group, which manages over $35 billion in assets.
Crescent Capital BDC, Inc. (CCAP) reported net investment income of $11.0 million ($0.39 per share) for Q2 2021, with adjusted net investment income at $14.8 million ($0.53 per share). The net asset value per share rose to $20.98 from $20.24 in Q1 2021. A cash dividend of $0.41 per share was declared for Q3 2021, payable on October 15, 2021. Total investments increased to $1,095.0 million. Investment income rose to $23.8 million from $20.6 million in Q1 2021, driven by portfolio expansion, while expenses climbed to $12.8 million due to capital gains-based fees.